Primary thyroid lymphoma: A clinical review

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 8, 2013, Pages 3131-3138

  Stein, Stephanie Aleskow ^a   Wartofsky, Leonard ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

CANCER RADIOTHERAPY; CASE STUDY; CLINICAL FEATURE; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; MARGINAL ZONE LYMPHOMA; MULTIPLE CYCLE TREATMENT; NECK TUMOR; PHYSICAL EXAMINATION; PRIMARY THYROID LYMPHOMA; PRIORITY JOURNAL; REVIEW; THYROID CANCER;

BIOPSY, FINE-NEEDLE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROGNOSIS; THYROID NEOPLASMS;

EID: 84881511500     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1428     Document Type: Review

References (47)

1. Sangalli G, Serio G, Zampatti C, Lomuscio G, Colombo L. Fine needle aspiration cytology of primary lymphoma of the thyroid: a report of 17 cases. Cytopathology. 2001;12:257-263.
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252-260.
3. Thieblemont C, Mayer A, Dumontet C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002; 87:105-111.
4. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology. 1996; 28:25-32.
5. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24: 623-639.
6. Sarinah B, Hisham AN. Primary lymphoma of the thyroid: diagnostic and therapeutic considerations. Asian J Surg. 2010;33:20-24.
7. Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1, 408 cases. Surgery. 2009;146: 1105-1115.
8. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3:93-99.
9. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis.NEngl J Med. 1985;312:601-604.
10. Jaffe ES. The 2008WHOclassification of lymphomas: implications for clinical practice and translational research. HematologyAmSoc Hematol Educ Program. 2009;523-531.
11. Alzouebi M, Goepel JR, Horsman JM, Hancock BW. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol. 2012;40:2075-2080.
12. Onal C, Li YX, Miller RC, et al. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study. Ann Oncol. 2011;22:156-164.
13. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol. 1988;19: 1315-1326.
14. Moshynska OV, Saxena A. Clonal relationship between hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008;61:438-444.
15. Watanabe N, Noh JY, Narimatsu H, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease. Br J Haematol. 2011;153:236-243.
16. Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid. 1999; 9:1273-1280.
17. Morgen EK, Geddie W, Boerner S, Bailey D, Santos Gda C. The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: a retrospective study of nine cases and review of published series. J Clin Pathol. 2010;63:129-133.
18. Rawal A, FinnWG, Schnitzer B, Valdez R. Site-specific morphologic differences in extranodal marginal zone B-cell lymphomas. Arch Pathol Lab Med. 2007;131:1673-1678.
19. Maitra A. The endocrine system. In: Kumar V, Abbas A, Fausto N, Aster JC, Perkins JA, eds. Robbins & Cotran Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders Elsevier; 2010:1097-1164.
20. Vega F, Lin P, Medeiros LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9:340-350.
21. Niitsu N, Okamoto M, Nakamura N, Nakamine H, Bessho M, Hirano M. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Ann Oncol. 2007;18:1203-1208.
22. Nam M, Shin JH, Han BK, et al. Thyroid lymphoma: correlation of radiologic and pathologic features. J Ultrasound Med. 2012;31: 589-594.
23. Ota H, Ito Y, Matsuzuka F, et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid. Thyroid. 2006; 16:983-987.
24. Young NA, Al-Saleem TI, Ehya H, Smith MR. Utilization of fineneedle aspiration cytology and flow cytometry in the diagnosis and subclassification of primary and recurrent lymphoma. Cancer. 1998;84:252-261.
25. Jeffers MD, Milton J, Herriot R, McKean M. Fine needle aspiration cytology in the investigation on non-Hodgkin's lymphoma. J Clin Pathol. 1998;51:189-196.
26. Sneige N, Dekmezian R, el-Naggar A, Manning J. Cytomorphologic, immunocytochemical, and nucleic acid flow cytometric study of 50 lymph nodes by fine-needle aspiration. comparison with results obtained by subsequent excisional biopsy. Cancer. 1991;67: 1003-1007.
27. Skarsgard ED, Connors JM, Robins RE. A current analysis of primary lymphoma of the thyroid. Arch Surg. 1991;126:1199-1203.
28. Cha C, Chen H, Westra WH, Udelsman R. Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? Ann Surg Oncol. 2002;9:298-302.
29. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971;31:1860-1861.
30. Takashima S, Morimoto S, Ikezoe J, et al. Primary thyroid lymphoma: comparison of CT and US assessment. Radiology. 1989; 171:439-443.
31. Basu S, Li G, Bural G, Alavi A. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Acta Radiol. 2009;50:201-204.
32. Arabi M, Dvorak R, Smith LB, Kujawski L, Gross MD. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis. Thyroid. 2011;21: 1153-1156.
33. Lin EC. FDG PET/CT for assessing therapy response in primary thyroid lymphoma. Clin Nucl Med. 2007;32:152-153.
34. Klyachkin ML, Schwartz RW, Cibull M, et al. Thyroid lymphoma: is there a role for surgery? Am Surg. 1998;64:234-238.
35. Blair TJ, Evans RG, Buskirk SJ, Banks PM, Earle JD. Radiotherapeutic management of primary thyroid lymphoma. Int J Radiat Oncol Biol Phys. 1985;11:365-370.
36. Pyke CM, Grant CS, Habermann TM, et al. Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary? World J Surg. 1992;16:604-610.
37. Friedberg MH, Coburn MC, Monchik JM. Role of surgery in stage IE non-Hodgkin's lymphoma of the thyroid. Surgery. 1994;116: 1061-1067.
38. Doria R, Jekel JF, Cooper DL. Thyroid lymphoma. The case for combined modality therapy. Cancer. 1994;73:200-206.
39. Vigliotti A, Kong JS, Fuller LM, Velasquez WS. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment. Int J Radiat Oncol Biol Phys. 1986;12:1807-1812.
40. Laing RW, Hoskin P, Hudson BV, et al. The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1994;6: 300-304.
41. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21: 4157-4164.
42. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;339:21-26.
43. Ha CS, Shadle KM, Medeiros LJ, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer. 2001;91:629-635.
44. Jonak C, Troch M, Mullauer L, Niederle B, Hoffmann M, Raderer M. Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid. Thyroid. 2010;20: 425-427.
45. Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weeklyCHOP-14with or without rituximab in elderly patients with aggressive CD20B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008;9:105-116.
46. Sippel RS, Gauger PG, Angelos P, ThompsonNW, MackE, Chen H. Palliative thyroidectomy for malignant lymphoma of the thyroid. Ann Surg Oncol. 2002;9:907-911.
47. Hopkins C, Stearns M, Watkinson AF. Palliative tracheal stenting in invasive papillary thyroid carcinoma. J Laryngol Otol. 2001;115:935-937.